Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role.

Rodríguez-Otero P, Mateos MV, Martínez-López J, Martín-Calvo N, Hernández MT, Ocio EM, Rosiñol L, Martínez R, Teruel AI, Gutiérrez NC, Bargay J, Bengoechea E, González Y, de Oteyza JP, Gironella M, Encinas C, Martín J, Cabrera C, Palomera L, de Arriba F, Cedena MT, Paiva B, Puig N, Oriol A, Bladé J, Lahuerta JJ, San Miguel JF.

Leukemia. 2018 Feb 23. doi: 10.1038/s41375-018-0072-6. [Epub ahead of print]

PMID:
29515235
2.

Tight junction protein claudin-2 promotes self-renewal of human colorectal cancer stem-like cells.

Paquet-Fifield S, Koh SL, Cheng L, Beyit LM, Shembrey CE, Moelck C, Behrenbruch C, Papin M, Gironella M, Guelfi S, Nasr R, Grillet F, Prudhomme M, Bourgaux JF, Castells A, Pascussi JM, Heriot AG, Puisieux A, Davis MJ, Pannequin J, Hill AF, Sloan EK, Hollande F.

Cancer Res. 2018 Mar 6. pii: canres.1869.2017. doi: 10.1158/0008-5472.CAN-17-1869. [Epub ahead of print]

PMID:
29510994
3.

Deciphering microRNA targets in pancreatic cancer using miRComb R package.

Vila-Casadesús M, Vila-Navarro E, Raimondi G, Fillat C, Castells A, Lozano JJ, Gironella M.

Oncotarget. 2018 Jan 8;9(5):6499-6517. doi: 10.18632/oncotarget.24034. eCollection 2018 Jan 19.

4.

Rare germline copy number variants in colorectal cancer predisposition characterized by exome sequencing analysis.

Franch-Expósito S, Esteban-Jurado C, Garre P, Quintanilla I, Duran-Sanchon S, Díaz-Gay M, Bonjoch L, Cuatrecasas M, Samper E, Muñoz J, Ocaña T, Carballal S, López-Cerón M, Castells A; EPICOLON consortium, Vila-Casadesús M, Derdak S, Laurie S, Beltran S, Carvajal J, Bujanda L, Ruiz-Ponte C, Camps J, Gironella M, Lozano JJ, Balaguer F, Cubiella J, Caldés T, Castellví-Bel S.

J Genet Genomics. 2018 Jan 20;45(1):41-45. doi: 10.1016/j.jgg.2017.12.001. Epub 2017 Dec 20. No abstract available.

PMID:
29396139
5.

BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC).

Benyamine A, Loncle C, Foucher E, Blazquez JL, Castanier C, Chrétien AS, Modesti M, Secq V, Chouaib S, Gironella M, Vila-Navarro E, Montalto G, Dagorn JC, Dusetti N, Iovanna J, Olive D.

Oncoimmunology. 2017 Sep 21;7(1):e1372080. doi: 10.1080/2162402X.2017.1372080. eCollection 2017.

PMID:
29296524
6.

Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials.

Arana P, Paiva B, Cedena MT, Puig N, Cordon L, Vidriales MB, Gutierrez NC, Chiodi F, Burgos L, Anglada LL, Martinez-Lopez J, Hernandez MT, Teruel AI, Gironella M, Echeveste MA, Rosiñol L, Martinez R, Oriol A, De la Rubia J, Orfao A, Blade J, Lahuerta JJ, Mateos MV, San Miguel JF.

Leukemia. 2018 Apr;32(4):971-978. doi: 10.1038/leu.2017.320. Epub 2017 Nov 3.

PMID:
29099494
7.

PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker.

Nigri J, Gironella M, Bressy C, Vila-Navarro E, Roques J, Lac S, Bontemps C, Kozaczyk C, Cros J, Pietrasz D, Maréchal R, Van Laethem JL, Iovanna J, Bachet JB, Folch-Puy E, Tomasini R.

Cell Mol Life Sci. 2017 Nov;74(22):4231-4243. doi: 10.1007/s00018-017-2579-9. Epub 2017 Jun 27.

PMID:
28656348
8.

Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.

Pineda E, Salud A, Vila-Navarro E, Safont MJ, Llorente B, Aparicio J, Vera R, Escudero P, Casado E, Bosch C, Bohn U, Pérez-Carrión R, Carmona A, Ayuso JR, Ripollés T, Bouzas R, Gironella M, García-Albéniz X, Feliu J, Maurel J.

Tumour Biol. 2017 Jun;39(6):1010428317705509. doi: 10.1177/1010428317705509.

9.

REG3β modifies cell tumor function by impairing extracellular vesicle uptake.

Bonjoch L, Gironella M, Iovanna JL, Closa D.

Sci Rep. 2017 Jun 9;7(1):3143. doi: 10.1038/s41598-017-03244-4.

10.

Further psychometric validation of the GAH scale: Responsiveness and effect size.

Cruz-Jentoft AJ, González B, de la Rubia J, Hernández Rivas JÁ, Soler JA, Fernández Lago C, Arnao M, Gironella M, Pérez Persona E, Zudaire MT, Olivier C, Altés A, García Guiñón A, Nomdedeu B, Arnan M, Ramírez Payer Á, Sánchez-Godoy P, Pajuelo N, Vilanova D, Monjil DF, Bonanad S; GAH Group.

J Geriatr Oncol. 2017 May;8(3):211-215. doi: 10.1016/j.jgo.2016.12.008. Epub 2016 Dec 22.

PMID:
28017687
11.

Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma.

Mateos MV, Granell M, Oriol A, Martinez-Lopez J, Blade J, Hernandez MT, Martín J, Gironella M, Lynch M, Bleickardt E, Paliwal P, Singhal A, San-Miguel J.

Br J Haematol. 2016 Nov;175(3):448-456. doi: 10.1111/bjh.14263. Epub 2016 Jul 19.

PMID:
27434748
12.

Pregnane X-receptor promotes stem cell-mediated colon cancer relapse.

Planque C, Rajabi F, Grillet F, Finetti P, Bertucci F, Gironella M, Lozano JJ, Beucher B, Giraud J, Garambois V, Vincent C, Brown D, Caillo L, Kantar J, Pelegrin A, Prudhomme M, Ripoche J, Bourgaux JF, Ginestier C, Castells A, Hollande F, Pannequin J, Pascussi JM.

Oncotarget. 2016 Aug 30;7(35):56558-56573. doi: 10.18632/oncotarget.10646.

13.

MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts.

Vila-Navarro E, Vila-Casadesús M, Moreira L, Duran-Sanchon S, Sinha R, Ginés À, Fernández-Esparrach G, Miquel R, Cuatrecasas M, Castells A, Lozano JJ, Gironella M.

Ann Surg. 2017 Jun;265(6):1226-1234. doi: 10.1097/SLA.0000000000001809.

14.

Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients.

Paiva B, Cedena MT, Puig N, Arana P, Vidriales MB, Cordon L, Flores-Montero J, Gutierrez NC, Martín-Ramos ML, Martinez-Lopez J, Ocio EM, Hernandez MT, Teruel AI, Rosiñol L, Echeveste MA, Martinez R, Gironella M, Oriol A, Cabrera C, Martin J, Bargay J, Encinas C, Gonzalez Y, Van Dongen JJ, Orfao A, Bladé J, Mateos MV, Lahuerta JJ, San Miguel JF; Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas (GEM/PETHEMA) Cooperative Study Groups.

Blood. 2016 Jun 23;127(25):3165-74. doi: 10.1182/blood-2016-03-705319. Epub 2016 Apr 26.

15.

MiRComb: An R Package to Analyse miRNA-mRNA Interactions. Examples across Five Digestive Cancers.

Vila-Casadesús M, Gironella M, Lozano JJ.

PLoS One. 2016 Mar 11;11(3):e0151127. doi: 10.1371/journal.pone.0151127. eCollection 2016.

16.

Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.

Paiva B, Corchete LA, Vidriales MB, Puig N, Maiso P, Rodriguez I, Alignani D, Burgos L, Sanchez ML, Barcena P, Echeveste MA, Hernandez MT, García-Sanz R, Ocio EM, Oriol A, Gironella M, Palomera L, De Arriba F, Gonzalez Y, Johnson SK, Epstein J, Barlogie B, Lahuerta JJ, Blade J, Orfao A, Mateos MV, San Miguel JF; Spanish Myeloma Group / Program for the Study of Malignant Blood Diseases Therapeutics (GEM / PETHEMA) Cooperative Study Groups.

Blood. 2016 Apr 14;127(15):1896-906. doi: 10.1182/blood-2015-08-665679. Epub 2016 Jan 11.

17.

Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM.

Mateos MV, Martínez-López J, Hernández MT, Ocio EM, Rosiñol L, Martínez R, Teruel AI, Gutiérrez NC, Martín Ramos ML, Oriol A, Bargay J, Bengoechea E, González Y, Pérez de Oteyza J, Gironella M, Encinas C, Martín J, Cabrera C, Paiva B, Cedena MT, Puig N, Bladé J, Lahuerta JJ, San-Miguel J.

Blood. 2016 Jan 28;127(4):420-5. doi: 10.1182/blood-2015-08-666537. Epub 2015 Oct 23.

18.

Response to "Is the Reg3α (HIP/PAP) Protein Really an Obesogenic Factor?".

Secq V, Mallmann C, Gironella M, Lopez B, Closa D, Garcia S, Christa L, Montalto G, Dusetti N, Iovanna JL.

J Cell Physiol. 2016 Jan;231(1):2. doi: 10.1002/jcp.25130. Epub 2015 Sep 1. No abstract available.

PMID:
26280560
19.

Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale.

Bonanad S, De la Rubia J, Gironella M, Pérez Persona E, González B, Fernández Lago C, Arnan M, Zudaire M, Hernández Rivas JA, Soler A, Marrero C, Olivier C, Altés A, Valcárcel D, Hernández MT, Oiartzabal I, Fernández Ordoño R, Arnao M, Esquerra A, Sarrá J, González-Barca E, González J, Calvo X, Nomdedeu M, García Guiñón A, Ramírez Payer A, Casado A, López S, Durán M, Marcos M, Cruz-Jentoft AJ; GAH Group.

J Geriatr Oncol. 2015 Sep;6(5):353-61. doi: 10.1016/j.jgo.2015.03.003. Epub 2015 Jun 29.

PMID:
26139300
20.

Assessment of amyloid deposits by (18)F-florbetapir positron emission tomography.

Martínez-Valle F, Gironella M, Riveiro-Barciela M, Lorenzo-Bosquet C.

Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1778-1779. doi: 10.1007/s00259-015-3108-4. Epub 2015 Jun 17. No abstract available.

PMID:
26081942
21.

Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial.

García-Sanz R, Oriol A, Moreno MJ, de la Rubia J, Payer AR, Hernández MT, Palomera L, Teruel AI, Blanchard MJ, Gironella M, Ribas P, Bargay J, Abellá E, Granell M, Ocio EM, Ribera JM, San Miguel JF, Mateos MV; Spanish Myeloma Group (GEM/PETHEMA).

Haematologica. 2015 Sep;100(9):1207-13. doi: 10.3324/haematol.2015.128439. Epub 2015 Jun 11.

22.

ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients.

Vargas T, Moreno-Rubio J, Herranz J, Cejas P, Molina S, González-Vallinas M, Mendiola M, Burgos E, Aguayo C, Custodio AB, Machado I, Ramos D, Gironella M, Espinosa-Salinas I, Ramos R, Martín-Hernández R, Risueño A, De Las Rivas J, Reglero G, Yaya R, Fernández-Martos C, Aparicio J, Maurel J, Feliu J, Ramírez de Molina A.

Oncotarget. 2015 Mar 30;6(9):7348-63.

23.

miR-148a- and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activity.

Bofill-De Ros X, Gironella M, Fillat C.

Mol Ther. 2014 Sep;22(9):1665-77. doi: 10.1038/mt.2014.98. Epub 2014 Jun 4.

24.

Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review.

Alegre A, Gironella M, Bailén A, Giraldo P.

Eur J Haematol. 2014 Mar;92(3):181-8. doi: 10.1111/ejh.12239. Epub 2014 Jan 10. Review.

PMID:
24330023
25.

Deciphering the binding between Nupr1 and MSL1 and their DNA-repairing activity.

Aguado-Llera D, Hamidi T, Doménech R, Pantoja-Uceda D, Gironella M, Santoro J, Velázquez-Campoy A, Neira JL, Iovanna JL.

PLoS One. 2013 Oct 30;8(10):e78101. doi: 10.1371/journal.pone.0078101. eCollection 2013.

26.

5q- syndrome and multiple myeloma diagnosed simultaneously and successful treated with lenalidomide.

Ortega M, Mallo M, Solé F, Sánchez-Morata C, López-Andreoni L, Martínez-Morgado N, Gironella M, Valcárcel D, Vallespí T.

Leuk Res. 2013 Oct;37(10):1248-50. doi: 10.1016/j.leukres.2013.06.021. Epub 2013 Jul 26.

PMID:
23891188
27.

PAP/HIP protein is an obesogenic factor.

Secq V, Mallmann C, Gironella M, Lopez B, Closa D, Garcia S, Christa L, Montalto G, Dusetti N, Iovanna JL.

J Cell Physiol. 2014 Feb;229(2):225-31. doi: 10.1002/jcp.24438.

PMID:
23881718
28.

Reg3β deficiency impairs pancreatic tumor growth by skewing macrophage polarization.

Gironella M, Calvo C, Fernández A, Closa D, Iovanna JL, Rosello-Catafau J, Folch-Puy E.

Cancer Res. 2013 Sep 15;73(18):5682-94. doi: 10.1158/0008-5472.CAN-12-3057. Epub 2013 Jul 18.

29.

Molecular markers in pancreatic cancer diagnosis.

Herreros-Villanueva M, Gironella M, Castells A, Bujanda L.

Clin Chim Acta. 2013 Mar 15;418:22-9. doi: 10.1016/j.cca.2012.12.025. Epub 2013 Jan 8. Review.

PMID:
23305796
30.

Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancer.

Bujanda L, Sarasqueta C, Cosme A, Hijona E, Enríquez-Navascués JM, Placer C, Villarreal E, Herreros-Villanueva M, Giraldez MD, Gironella M, Balaguer F, Castells A.

PLoS One. 2013;8(1):e51810. doi: 10.1371/journal.pone.0051810. Epub 2013 Jan 2.

31.

Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study.

Giráldez MD, Lozano JJ, Ramírez G, Hijona E, Bujanda L, Castells A, Gironella M.

Clin Gastroenterol Hepatol. 2013 Jun;11(6):681-8.e3. doi: 10.1016/j.cgh.2012.12.009. Epub 2012 Dec 23.

PMID:
23267864
32.

Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain.

Sanchez-Gonzalez B, Peñalver FJ, Medina A, Guillén H, Calleja M, Gironella M, Arranz R, Sebastian E, de Oña R, Cánovas A, de la Fuente I, Grande C, Sancho JM, Perez R, Domingo E, Lopez-Lorenzo JL, Prieto E, Panizo C, Gorosquieta A, Perez I, Cervera JM, Marin M, Mencha C, Ramila E, Salar A.

Leuk Res. 2012 Jun;36(6):709-14. doi: 10.1016/j.leukres.2011.10.024. Epub 2011 Dec 7.

PMID:
22154023
33.

Colorectal cancers with microsatellite instability display unique miRNA profiles.

Balaguer F, Moreira L, Lozano JJ, Link A, Ramirez G, Shen Y, Cuatrecasas M, Arnold M, Meltzer SJ, Syngal S, Stoffel E, Jover R, Llor X, Castells A, Boland CR, Gironella M, Goel A.

Clin Cancer Res. 2011 Oct 1;17(19):6239-49. doi: 10.1158/1078-0432.CCR-11-1424. Epub 2011 Aug 15.

34.

p8/nupr1 regulates DNA-repair activity after double-strand gamma irradiation-induced DNA damage.

Gironella M, Malicet C, Cano C, Sandi MJ, Hamidi T, Tauil RM, Baston M, Valaco P, Moreno S, Lopez F, Neira JL, Dagorn JC, Iovanna JL.

J Cell Physiol. 2009 Dec;221(3):594-602. doi: 10.1002/jcp.21889.

PMID:
19650074
35.

Clinical management of thrombosis in inherited factor VII deficiency: a description of two cases.

Arellano-Rodrigo E, Gironella M, Nicolau I, Vila M.

Thromb Haemost. 2009 Feb;101(2):402-4. No abstract available.

PMID:
19190828
36.

Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis.

Dessein R, Gironella M, Vignal C, Peyrin-Biroulet L, Sokol H, Secher T, Lacas-Gervais S, Gratadoux JJ, Lafont F, Dagorn JC, Ryffel B, Akira S, Langella P, Nùñez G, Sirard JC, Iovanna J, Simonet M, Chamaillard M.

Gut. 2009 Jun;58(6):771-6. doi: 10.1136/gut.2008.168443. Epub 2009 Jan 27.

PMID:
19174417
37.

Early molecular and functional changes in colonic epithelium that precede increased gut permeability during colitis development in mdr1a(-/-) mice.

Collett A, Higgs NB, Gironella M, Zeef LA, Hayes A, Salmo E, Haboubi N, Iovanna JL, Carlson GL, Warhurst G.

Inflamm Bowel Dis. 2008 May;14(5):620-31. doi: 10.1002/ibd.20375.

PMID:
18275070
38.

Time course of anti-inflammatory effect of low-dose radiotherapy: correlation with TGF-beta(1) expression.

Arenas M, Gil F, Gironella M, Hernández V, Biete A, Piqué JM, Panés J.

Radiother Oncol. 2008 Mar;86(3):399-406. Epub 2007 Nov 26.

PMID:
18031855
39.

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.

Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, Pébusque MJ, Dusetti NJ.

Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16170-5. Epub 2007 Oct 2.

40.

Experimental acute pancreatitis in PAP/HIP knock-out mice.

Gironella M, Folch-Puy E, LeGoffic A, Garcia S, Christa L, Smith A, Tebar L, Hunt SP, Bayne R, Smith AJ, Dagorn JC, Closa D, Iovanna JL.

Gut. 2007 Aug;56(8):1091-7. Epub 2007 Apr 4.

41.

Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1.

Gommeaux J, Cano C, Garcia S, Gironella M, Pietri S, Culcasi M, Pébusque MJ, Malissen B, Dusetti N, Iovanna J, Carrier A.

Mol Cell Biol. 2007 Mar;27(6):2215-28. Epub 2007 Jan 22.

42.

Anti-inflammatory effects of low-dose radiotherapy in an experimental model of systemic inflammation in mice.

Arenas M, Gil F, Gironella M, Hernández V, Jorcano S, Biete A, Piqué JM, Panés J.

Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):560-7.

PMID:
16965998
43.

Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis.

Angulo S, Llopis M, Antolín M, Gironella M, Sans M, Malagelada JR, Piqué JM, Guarner F, Panés J.

Am J Physiol Gastrointest Liver Physiol. 2006 Dec;291(6):G1155-62. Epub 2006 Aug 10.

44.

Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.

Carracedo A, Gironella M, Lorente M, Garcia S, Guzmán M, Velasco G, Iovanna JL.

Cancer Res. 2006 Jul 1;66(13):6748-55.

45.

The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.

Carracedo A, Lorente M, Egia A, Blázquez C, García S, Giroux V, Malicet C, Villuendas R, Gironella M, González-Feria L, Piris MA, Iovanna JL, Guzmán M, Velasco G.

Cancer Cell. 2006 Apr;9(4):301-12.

46.

p8 is a new target of gemcitabine in pancreatic cancer cells.

Giroux V, Malicet C, Barthet M, Gironella M, Archange C, Dagorn JC, Vasseur S, Iovanna JL.

Clin Cancer Res. 2006 Jan 1;12(1):235-41.

47.

Down-regulation of endothelial adhesion molecules and leukocyte adhesion by treatment with superoxide dismutase is beneficial in chronic immune experimental colitis.

Seguí J, Gil F, Gironella M, Alvarez M, Gimeno M, Coronel P, Closa D, Piqué JM, Panés J.

Inflamm Bowel Dis. 2005 Oct;11(10):872-82.

PMID:
16189416
48.

Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice.

Justicia C, Martín A, Rojas S, Gironella M, Cervera A, Panés J, Chamorro A, Planas AM.

J Cereb Blood Flow Metab. 2006 Mar;26(3):421-32.

PMID:
16079786
49.

Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.

Gironella M, Iovanna JL, Sans M, Gil F, Peñalva M, Closa D, Miquel R, Piqué JM, Panés J.

Gut. 2005 Sep;54(9):1244-53. Epub 2005 May 3.

50.

Protective effect of superoxide dismutase in radiation-induced intestinal inflammation.

Mollà M, Gironella M, Salas A, Closa D, Biete A, Gimeno M, Coronel P, Piqué JM, Panés J.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1159-66.

PMID:
15752897

Supplemental Content

Loading ...
Support Center